Abstract
Infection with SARS-CoV-2 causes wide range of disease severities from asymptomatic to life-threatening disease. Understanding the contribution of immunological traits in immunity against SARS-CoV-2 and in protection against severe COVID-19 could result in effective measures to prevent development of severe disease. While the role of cytokines and antibodies has been thoroughly studied, this is not the case for T cells. In this review, the association between T cells and COVID-19 disease severity and protection upon reexposure is discussed. While infiltration of overactivated cytotoxic T cells might be harmful in the infected tissue, fast responding T cells are important in the protection against severe COVID-19. This protection could even be viable in the long term as long-living memory T cells seem to be stabilized and mutations do not appear to have a large impact on T cell responses. Thus, after vaccination and infections, memory T cells should be able to help prevent onset of severe disease for most cases. Considering this, it would be useful to add N or M proteins in vaccinations, alongside the S protein which is currently used, as this results in a broader T cell response.
| Original language | English |
|---|---|
| Pages (from-to) | 295-307 |
| Number of pages | 13 |
| Journal | Immunogenetics |
| Volume | 75 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - Jun 2023 |
Bibliographical note
Publisher Copyright:© 2023, The Author(s).
Keywords
- Protection against severe COVID-19
- SARS-CoV-2
- T cell immunity
- Vaccination